# KINNATE BIOPHARMA INC (KNTE)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/KNTE/

- Reporting holders: 55
- Reported value: $98.0M
- Held through calls: 0.3%
- Held through puts: 5.6%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Foresite Capital Management IV, LLC](https://holderbook.com/funds/1704132-foresite-capital-management-iv-llc/) | $25.7M | 9,671,643 | 13.0% | 14 |
| [ORBIMED ADVISORS LLC](https://holderbook.com/funds/1055951-orbimed-advisors-llc/) | $21.3M | 8,009,729 | 0.4% | 14 |
| [Foresite Capital Management V, LLC](https://holderbook.com/funds/1792206-foresite-capital-management-v-llc/) | $9.4M | 3,525,957 | 8.8% | 14 |
| [Lynx1 Capital Management LP](https://holderbook.com/funds/1910456-lynx1-capital-management-lp/) | $5.3M | 1,981,106 | 1.4% | 9 |
| [VIKING GLOBAL INVESTORS LP](https://holderbook.com/funds/1103804-viking-global-investors-lp/) | $4.8M | 1,820,462 | 0.0% | 14 |
| [GROUP ONE TRADING, L.P.](https://holderbook.com/funds/932540-group-one-trading-l-p/) | $4.3M | 354,121 | 0.0% | 4 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $3.3M | 526,021 | 0.0% | 5 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $2.9M | 1,076,789 | 0.0% | 14 |
| [DELTEC ASSET MANAGEMENT LLC](https://holderbook.com/funds/1269950-deltec-asset-management-llc/) | $2.8M | 1,039,800 | 0.5% | 1 |
| [TANG CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/1232621-tang-capital-management-llc/) | $2.6M | 977,626 | 0.3% | 2 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $2.6M | 964,881 | 0.0% | 8 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $2.4M | 887,740 | 0.0% | 9 |
| [BML Capital Management, LLC](https://holderbook.com/funds/1616824-bml-capital-management-llc/) | $1.3M | 498,851 | 0.9% | 2 |
| [Yakira Capital Management, Inc.](https://holderbook.com/funds/1584639-yakira-capital-management-inc/) | $1.3M | 496,840 | 0.4% | 1 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $1.1M | 431,406 | 0.0% | 14 |
| [GSA CAPITAL PARTNERS LLP](https://holderbook.com/funds/1362033-gsa-capital-partners-llp/) | $890.0K | 334,694 | 0.1% | 9 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $711.2K | 267,355 | 0.0% | 4 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $649.6K | 244,151 | 0.0% | 14 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $578.5K | 214,664 | 0.0% | 14 |
| [EQUITEC PROPRIETARY MARKETS, LLC](https://holderbook.com/funds/1143261-equitec-proprietary-markets-llc/) | $536.0K | 103,000 | 0.3% | 1 |
| [MARSHALL WACE, LLP](https://holderbook.com/funds/1318757-marshall-wace-llp/) | $415.2K | 156,089 | 0.0% | 4 |
| [Trium Capital LLP](https://holderbook.com/funds/1963860-trium-capital-llp/) | $312.0K | 117,456 | 0.1% | 1 |
| [DEUTSCHE BANK AG\](https://holderbook.com/funds/948046-deutsche-bank-ag/) | $305.5K | 114,846 | 0.0% | 13 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $277.8K | 104,437 | 0.0% | 4 |
| [DIMENSIONAL FUND ADVISORS LP](https://holderbook.com/funds/354204-dimensional-fund-advisors-lp/) | $244.6K | 91,961 | 0.0% | 8 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 55 | $98.0M |
| Q4 2023 | 61 | $95.9M |
| Q3 2023 | 57 | $54.0M |
| Q2 2023 | 71 | $121.4M |
| Q1 2023 | 71 | $281.1M |
| Q4 2022 | 79 | $249.0M |
| Q3 2022 | 83 | $521.3M |
| Q2 2022 | 72 | $544.2M |
| Q1 2022 | 77 | $465.5M |
| Q4 2021 | 69 | $750.8M |
| Q3 2021 | 72 | $905.1M |
| Q2 2021 | 61 | $890.9M |